Curelab Veterinary
Dedham, US · Founded 2020 · Delaware corporation
Find your way into Curelab Veterinary
Sign up to see every warm intro you have to Curelab Veterinary
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Curelab Veterinary team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CureLab Veterinary develops ElenaVet, a plasmid DNA gene therapy encoding the p62/SQSTM1 protein to reduce chronic inflammation and enhance anticancer immune response in pets, targeting conditions such as breast cancer, melanoma, osteoarthritis and inflammatory bowel disease in dogs, cats and horses. The company works with academic and private veterinary clinics through comparative medicine studies and is a sister company of CureLab Oncology, which focuses on human immuno-oncology.
Founders & leadership
Curelab Veterinary was founded in 2020 by Alexander Shneider.




Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 1 round · 2022
▶$2.5MraisedDec 2022 · 1 investors · BiotechnologyRule 506(b)
- Jason PayneExecutive Officer
- Alex ShneiderExecutive Officer
- Robert DevlinExecutive Officer
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- Minimum investment
- $10K
- Proceeds to insiders
- $200K
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Curelab Veterinary.
In the news
Frequently asked questions
- What does Curelab Veterinary do?
- CureLab Veterinary develops ElenaVet, a plasmid DNA gene therapy encoding the p62/SQSTM1 protein to reduce chronic inflammation and enhance anticancer immune response in pets, targeting conditions such as breast cancer, melanoma, osteoarthritis and inflammatory bowel disease in dogs, cats and horses. The company works with academic and private veterinary clinics through comparative medicine studies and is a sister company of CureLab Oncology, which focuses on human immuno-oncology.
- Who founded Curelab Veterinary?
- Curelab Veterinary was founded by Alexander Shneider in 2020.
- How much funding has Curelab Veterinary raised?
- Curelab Veterinary has disclosed $2.5M raised across 1 round.
- Where is Curelab Veterinary headquartered?
- Curelab Veterinary is headquartered in Dedham, US.

